Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 7;10(12):2243-54.
doi: 10.2215/CJN.07590714. Epub 2015 May 4.

Cytokines: Names and Numbers You Should Care About

Affiliations
Review

Cytokines: Names and Numbers You Should Care About

Stephen R Holdsworth et al. Clin J Am Soc Nephrol. .

Abstract

Cytokines play an important role in host defense against microorganisms. They orchestrate innate immunity by inducing protective local inflammation and systemic acute phase responses. Cytokines are important in initiating, amplifying, directing, mediating, and regulating adaptive immunity. Unfortunately, they may also direct tissue damage if excessive responses occur or if they are involved in directing and mediating autoimmunity. Under these circumstances, cytokines are potential therapeutic targets. Over the last 20 years, we have seen the successful development and clinical implementation of biologic strategies that target key cytokines in specific inflammatory diseases with efficacy, specificity, and toxicity profiles challenging conventional drug therapies. These therapies are finding new applications and many new agents show promise. Unfortunately, these new cytokine-based therapies have had little effect on renal disease. This review provides evidence that common renal diseases, including those causing AKI and the autoimmune proliferative and crescentic forms of GN, have cytokine mediation profiles that suggest they would be susceptible to cytokine-targeting therapeutic strategies.

Keywords: clinical trial; cytokines; nephrology.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Production of major acute innate cytokines involved in local and systemic responses following leukocyte activation via TLRs or danger-associated molecular pattern receptors. DC, dendritic cell; GM-CSF, granulocyte-macrophage colony–stimulating factor; MC, mast cell; Rc, receptor; TLR, Toll-like receptor.
Figure 2.
Figure 2.
Innate macrophages produce IL-1 which binds to IL-1Rc on intrinsic renal cells (endothelial cells, podocytes, and mesangial cells) to produce injurious TNF-α that amplifies T effector cell responses resulting in crescent formation and glomerular injury. Rc, receptor.

Similar articles

Cited by

References

    1. Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I, Lawson BR: Toll-like receptors and their role in renal pathologies. Inflamm Allergy Drug Targets 11: 464–477, 2012 - PubMed
    1. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448–454, 1999 - PubMed
    1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357, 1986 - PubMed
    1. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233–240, 2005 - PMC - PubMed
    1. Kaplan MH: Th9 cells: Differentiation and disease. Immunol Rev 252: 104–115, 2013 - PMC - PubMed

MeSH terms